Comparing PBMC Preparation Methods for HIV Research
Author Information
Author(s): Joyce J Ruitenberg, Candice B Mulder, Vernon C Maino, Alan L Landay, Smita A Ghanekar
Primary Institution: BD Biosciences, San Jose, CA, USA
Hypothesis
Can CPT-processed PBMC be a viable alternative to Ficoll-processed PBMC in maintaining quality and function?
Conclusion
CPT is an efficient system for collecting and cryopreserving functionally active HIV+ PBMC, performing equivalently to Ficoll gradient separation.
Supporting Evidence
- CPT-processed PBMC showed equivalent viability and functionality compared to Ficoll-processed PBMC after cryopreservation.
- Fresh Ficoll-processed PBMC had significantly better viability than fresh CPT-processed PBMC.
- Both processing methods yielded similar numbers of viable cells post-cryopreservation.
Takeaway
This study looked at two ways to prepare blood samples from HIV patients and found that both methods work equally well for keeping the cells healthy.
Methodology
The study compared PBMC preparation methods using whole blood from HIV+ patients, assessing viability, recovery, and functional responses.
Potential Biases
Potential operator variability due to different processing methods.
Limitations
The study did not investigate the reasons for cell loss during processing.
Participant Demographics
19 HIV+ patients with CD4 > 350 and viral load < 50, all on HAART.
Statistical Information
P-Value
0.0005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website